Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.
<h4>Background</h4>Cancer causes significant morbidity and mortality among HIV patients in the US due to extended life expectancy with access to effective antiretroviral therapy. Low, detectable HIV RNA has been studied as a risk factor for adverse health outcomes, but its clinical impac...
Full description
Bibliographic Details
| Published in: | PLoS ONE |
| Main Authors: |
Jennifer S Lee,
Stephen R Cole,
Chad J Achenbach,
Dirk P Dittmer,
David B Richardson,
William C Miller,
Christopher Mathews,
Keri N Althoff,
Richard D Moore,
Joseph J Eron,
Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) |
| Format: | Article
|
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Online Access: | https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0197665/1/pone.0197665.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210223%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210223T095257Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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
|